Cefepime

• Cefepime is a powerful fourth-generation cephalosporin antibiotic.
• It is primarily used to treat serious bacterial infections, including pneumonia, urinary tract infections, and febrile neutropenia.
• Its mechanism involves inhibiting bacterial cell wall synthesis, leading to bacterial death.
• Administration is typically intravenous, with dosage adjusted based on infection severity and renal function.
• Common side effects include gastrointestinal disturbances and injection site reactions, while more serious effects are rare but possible.

What is Cefepime: Uses and Mechanism of Action

Cefepime is an injectable, broad-spectrum, fourth-generation cephalosporin antibiotic. It is distinguished by its enhanced activity against a wide range of bacteria, including many multi-drug resistant strains, making it a crucial agent in the treatment of serious hospital-acquired infections.

Cefepime is primarily used for the treatment of moderate to severe infections caused by susceptible bacteria. Its clinical applications include complicated urinary tract infections, complicated intra-abdominal infections, pneumonia (including hospital-acquired pneumonia), and empirical treatment of febrile neutropenia. It is particularly valuable in situations where resistance to other antibiotics is a concern, such as infections caused by Pseudomonas aeruginosa and extended-spectrum beta-lactamase (ESBL)-producing organisms.

The cefepime mechanism of action involves interfering with bacterial cell wall synthesis. Like other beta-lactam antibiotics, Cefepime binds to penicillin-binding proteins (PBPs) located on the inner bacterial cytoplasmic membrane. These PBPs are essential enzymes involved in the final stages of peptidoglycan synthesis, which forms the rigid structure of the bacterial cell wall. By inhibiting these enzymes, Cefepime prevents the cross-linking of peptidoglycan units, leading to a defective and weakened cell wall. This ultimately results in bacterial cell lysis and death.

Cefepime Dosage, Administration, and Side Effects

Cefepime dosage and administration are highly individualized, depending on the type and severity of the infection, the patient’s age, weight, and renal function. It is administered intravenously (IV) over 30 minutes, typically every 8 or 12 hours. For patients with impaired renal function, dosage adjustments are critical to prevent accumulation and potential neurotoxicity. The duration of treatment varies but usually ranges from 7 to 10 days, or longer for more severe or complicated infections.

Like all antibiotics, cefepime antibiotic side effects can occur, ranging from mild to severe. Common side effects are generally mild and transient:

• Diarrhea
• Nausea and vomiting
• Headache
• Rash
• Injection site reactions (pain, inflammation)

More serious, though less common, side effects can include Clostridioides difficile-associated diarrhea (CDAD), seizures, encephalopathy, and other central nervous system disturbances, particularly in patients with renal impairment who receive unadjusted doses. Allergic reactions, including anaphylaxis, are also possible and require immediate medical attention. Patients should report any unusual or severe symptoms to their healthcare provider.